Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 61 pseudogene (RNU7-61P) is a **pseudogene** related to the U7 small nuclear RNA gene family[1]. U7 snRNA itself is a functional RNA molecule that forms part of the U7 small nuclear ribonucleoprotein (snRNP) complex, which is essential for the processing of the 3’ end of histone pre-mRNAs in eukaryotic cells[5][6]. However, RNU7-61P is annotated as a *pseudogene*, meaning it resembles the structure of the functional RNU7 gene but is believed to be non-functional—typically not transcribed or not involved in the canonical biological activities of U7 snRNA[1]. Pseudogenes like RNU7-61P are generally considered biologically inactive; they usually do not encode functional RNAs or proteins and do not participate in therapeutic targeting. There is no evidence that RNU7-61P is a receptor, enzyme, transporter, or other molecular target of drugs or used in clinical diagnostics. Therefore, this entry appears on gene and genomics databases as a non-functional genetic element and not as a therapeutic target[1]. No information is available linking RNU7-61P to disease, phenotypic outcomes, or drug response. If you are seeking information on the active gene (functional U7 snRNA and its role in histone mRNA processing), you should refer to RNU7-1 or closely related U7 small nuclear RNA genes, not this pseudogene locus[3][4][5][6][7].
null (no known mechanism of action as a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 61 pseudogene (RNU7-61P).